.png){kind=logo}
Introducing the new Instinct sensor, made by Abbott
Life with diabetes just got easier
Managing diabetes is a daily commitment — and the right tools make all the difference. That's why we're excited to introduce the Instinct sensor, made by Abbott, now available in the U.S. The Instinct sensor is a 15-day continuous glucose monitoring (CGM) sensor built exclusively for MiniMed pump users. It pairs with our insulin delivery systems to make diabetes management simpler, more comfortable, and more flexible than ever.
What is the Instinct sensor?
The Instinct sensor is a small, discreet,¹ and comfortable² to wear CGM sensor that tracks your glucose levels continuously — no fingersticks required with SmartGuardTM technology.†
Instinct sensor highlights at a glance
| Feature | Details |
Wear time | 15 days |
Size | Smaller than two stacked pennies |
Insertion | Easy one-handed application |
Warm-up time | Just 1 hour |
Fingersticks | Not required with SmartGuard technology† |
Overtape | Not required |
Labeled for | People with type 1 ages 7 and over and insulin-requiring type 2 ages 18 and over. |
Why these features matter
- One-handed insertion means you can apply it quickly and easily — even on your own.
- Small and discreet1 sensor lets you wear it confidently under clothing or during activities.
- 15-day wear means fewer sensor changes and less hassle throughout your month.
- No fingersticks required with SmartGuard technology† simplifies your daily routine.
- No overtape needed keeps wear comfortable and clean from day one.
Where do you wear the Instinct sensor?
The Instinct sensor is designed and approved for wear on the back of the upper arm.
Which MiniMed systems work with the Instinct sensor?
The Instinct sensor is compatible with three MiniMed systems, giving you the flexibility to choose the right fit for your lifestyle.
MiniMed FlexTM
The MiniMed Flex is our latest automated insulin delivery (AID) system. It features:
- A small, sleek insulin pump
- CGM sensor
- SmartGuardTM advanced hybrid closed-loop technology
- The MiniMedTM app to control your pump from your phone
The Instinct sensor pairs seamlessly with MiniMed Flex for a fully connected diabetes management experience.
MiniMed GoTM
MiniMed Go is a smart multiple daily injections (MDI) system that combines:
- The InPenTM smart insulin pen
- CGM sensor
- One easy-to-use app
MiniMed Go remembers your insulin doses, reminds you when more is needed, and recommends smart actions — so you can focus on feeling your best.3
MiniMedTM 780G
The Instinct sensor is also compatible with our MiniMed 780G system, the #1 pump in preventing highs and lows based on user satisfaction.4-6
Sensor choice is here
Our expanded sensor selection allows our customers to choose the option that best fits their needs and lifestyle. In addition to the Instinct sensor, we also offer the Simplera SyncTM sensor. The Simplera Sync sensor is an all-in-one disposable option built for simplicity. Quick to apply, about the size of a quarter, and no overtape needed.
Both sensors are available for people living with type 1 or insulin-requiring type 2 diabetes.
See our full CGM comparison chart to explore the differences between sensor options side by side.
Ready to try the Instinct sensor?
Whether you're a new or current customer, there's a sensor option designed to work with you.
New to MiniMed?
Current customer?
Footnotes
† Fingersticks required in manual mode & to enter SmartGuardTM. If symptoms don’t match alerts & readings, use a fingerstick. Refer to user guide. Pivotal trial participants spend avg of > 93% in SmartGuard.
References
- Data on file, Abbott Diabetes Care, Inc.
- Alva, Shridhara, Ronald Brazg, Kristin Castorino, Mark Kipnes, David R. Liljenquist, and Hanqing Liu. "Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System." Diabetes Therapy 14, no. 4 (2023):767-776. https://doi.org/10.1007/s13300-023-01385-6
- Proper pairing, connectivity, and settings required. Prescription only. Talk to your healthcare professional before establishing and changing your settings. Ensure that all doses taken with InPen are logged in the app, that all doses taken with a device other than InPen are logged manually in the app, and that glucose and meal information entered into the dose calculator are current and accurate. Not doing so can result in incorrect dosing, hypoglycemia or hyperglycemia, and serious injury.
- Adults, T1 and parents of children with T1 diabetes < 18 years were surveyed
- Individual results may vary.
- dQ&A US Patient Voice Q2 2025.p. 77. N=215
Important Safety Information: MiniMed FlexTM system with SmartGuardTM technology with Simplera SyncTM sensor and Instinct sensor
The MiniMed FlexTM system is intended for the continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose values in the fluid under the skin.
The MiniMed FlexTM system includes SmartGuardTM technology, which can be programmed to automatically adjust insulin delivery based on continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values. The system is intended for use with connected sensors, including the Simplera SyncTM sensor and integrated continuous glucose monitors, including the Instinct sensor, each of which has different wear-time, form factor, insertion site, and other distinguishing characteristics that relate to sensor performance. Consult the appropriate sensor user guide when using the system. Discuss treatment decisions with your HCP.
WARNING: Do not use the SmartGuardTM feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuardTM feature.
WARNING: Do not use the MiniMedTM Flex system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMedTM Flex system.
WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuardTM feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.
Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed FlexTM system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including user guides and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, see https://link.minimed.com/Risks.
©2026 Medtronic MiniMed, Inc. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. The sensor shape and appearance, Abbott, and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under license. Sensor image ©2026 Abbott. TM*Third–party brands are trademarks of their respective owners.
Important safety information: MiniMed Go system
The MiniMed Go system includes the MiniMed Go app, InPen smart insulin pen injector and either the Instinct continuous glucose monitoring (CGM) sensor or Simplera CGM sensor. The system is intended to aid in diabetes management through multiple daily injections of compatible rapid-acting insulins (Humalog, Novolog, or Fiasp). The app and system components each require a prescription. When used with Instinct CGM, the app is indicated for patients ages 7 years and older, or patients ages 2 to 6 years under the supervision of an adult caregiver. When used with Simplera CGM, the app is indicated for patients ages 18 and over. If using InPen alone, the app is intended for all ages, with patients under age 7 requiring supervision. Use of these systems requires, among other things, adequate hearing and vision, a compatible mobile device and operating system, an open app, adequate pairing and connectivity, proper setting, use of an approved rapid-acting insulin, mobile device battery power, proper settings, accurate manual logging of insulin doses administered by means other than InPen, and occasional blood glucose meter (BGM) readings. Establishment of settings and treatment decisions should be made in consultation with a healthcare professional and on the basis of a combination of glucose readings, trend arrows, glucose target, active alerts, and recent events (such as insulin doses, exercise, meals, and medications). Failure to observe these and other details as found in the user guides can result in incorrect dosing, missed alerts and notifications, and ultimately hypoglycemia or hyperglycemia, with serious injury or death possible. For additional safety information and user guides, see https://link.minimed.com/Risks.
Important Safety Information: MiniMedTM 780G system with SmartGuardTM technology with Instinct sensor, Simplera SyncTM sensor, and GuardianTM 4 sensor
The MiniMedTM 780G system is intended for the continuous delivery of basal insulin at selectable rates and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose vales in the fluid under the skin.
The MiniMedTM 780G System includes SmartGuardTM technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values. The system is intended for use with connected sensors, including the Simplera SyncTM and GuardianTM 4 sensors and integrated continuous glucose monitors, including the Instinct sensor, each of which has different wear-time, form factor, insertion site, and other distinguishing characteristics that relate to sensor performance. Consult the appropriate sensor user guide when using the system. Discuss treatment decisions with your HCP.
WARNING: Do not use the SmartGuardTM feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuardTM feature.
WARNING: Do not use MiniMedTM 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of MiniMedTM 780G system.
WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuardTM feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.
Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMedTM 780G system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including user guides and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, see https://link.minimed.com/Risks.
©2026 Medtronic MiniMed, Inc. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. The sensor shape and appearance, Abbott, and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under license. Sensor image ©2026 Abbott. TM*Third–party brands are trademarks of their respective owners.
DreaMed Diabetes is a trademark of DreaMed Diabetes, Ltd. The MiniMedTM 780G system algorithm includes technology developed by DreaMed Diabetes.